home / stock / anab / anab articles

ANAB Articles, AnaptysBio Inc. - From 11/01/23

Stock Information
Company Name: AnaptysBio Inc.
Stock Symbol: ANAB
Market: NASDAQ
Website: anaptysbio.com
Menu
ANAB ANAB Quote ANAB Short ANAB News ANAB Articles ANAB Message Board
Get ANAB Alerts

News, Short Squeeze, Breakout and More Instantly...
Anaptys Announces Participation in November Investor Conferences | Benzinga

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innova...
Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist Antibody, at the 32nd EADV Congress | Benzinga

SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innova...

Why Is Skin Disease Focused AnaptysBio Stock Trading Higher Today? | Benzinga

AnaptysBio Inc (NASDAQ: ANAB) released topline results from its global Phase 3 GEMINI-1 trial of imsidolimab (IL-36R mAb) in patients with gen...

Anaptys to Provide Overview of Rosnilimab, a PD-1 Agonist, at Virtual R&D Event on Wednesday, Oct. 25 | Benzinga

Webcast at 4:15pm ET/1:15pm PT on Wednesday, Oct. 25 SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-s...
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors | Benzinga

After more than 15 years serving on AnaptysBio's Board of Directors, Jamie Topper, M.D., Ph.D., is stepping down and will serve as an adviso...

AnaptysBio to Present at the Stifel 2023 Immunology and Inflammation Virtual Summit | Benzinga

SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innov...

Previous 10 Next 10